Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.

Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.
复制标题

DOI:
10.1021/acs.molpharmaceut.5b00335
复制
发表时间:
2015-12-07
影响因子:
4.9
通讯作者:
Akala EO
Akala EO
中科院分区:
医学2区
文献类型:
--
作者:
Adesina SK;Akala EO

文献摘要

参考文献

被引文献

相似文献

RNA干扰(RNAi)是由大约21-23个核苷酸长的寡核苷酸触发的,能够诱导互补mRNA的破坏。RNAi技术已成功用于靶向HIV复制;然而,该技术在体内成功应用的主要限制是裸siRNA由于其强阴离子电荷和大分子量而无法通过扩散穿过细胞膜。本文综述了目前用于治疗HIV感染的递送抗HIV sirna的非病毒纳米技术方法。
RNA interference (RNAi) is triggered by oligonucleotides that are about 21–23 nucleotides long and are capable of inducing the destruction of complementary mRNA. The RNAi technique has been successfully utilized to target HIV replication; however, the main limitation to the successful utilization of this technique in vivo is the inability of naked siRNA to cross the cell membrane by diffusion due to its strong anionic charge and large molecular weight. This review describes current nonviral nanotechnological approaches to deliver anti-HIV siRNAs for the treatment of HIV infection.
DOI: 10.1186/1556-276x-9-252
发表时间: 2014
影响因子: --
作者:
Dizaj SM;Jafari S;Khosroushahi AY
通讯作者: Khosroushahi AY
DOI: 10.1016/0032-3861(95)90689-y
发表时间: 1995-01-01
期刊: POLYMER
影响因子: 4.6
作者:
EGUIBURU, JL;BERRIDI, MJF;SANROMAN, J
通讯作者: SANROMAN, J
DOI: 10.4081/idr.2011.e11
发表时间: 2011-09-07
影响因子: 3.2
作者:
Eszterhas SK;Ilonzo NO;Crozier JE;Celaj S;Howell AL
通讯作者: Howell AL
DOI: 10.1021/bc060367e
发表时间: 2007-09-01
影响因子: 4.7
作者:
Derfus, Austin M.;Chen, Alice A.;Bhatia, Sangeeta N.
通讯作者: Bhatia, Sangeeta N.
DOI: 10.1186/1556-276x-8-102
发表时间: 2013-02-22
影响因子: --
作者:
Akbarzadeh A;Rezaei-Sadabady R;Davaran S;Joo SW;Zarghami N;Hanifehpour Y;Samiei M;Kouhi M;Nejati-Koshki K
通讯作者: Nejati-Koshki K